nodes	percent_of_prediction	percent_of_DWPC	metapath
Methadone—CYP1A2—Dacarbazine—muscle cancer	0.0958	0.109	CbGbCtD
Methadone—CYP3A7-CYP3A51P—Vincristine—muscle cancer	0.0916	0.104	CbGbCtD
Methadone—CYP3A7—Vincristine—muscle cancer	0.0916	0.104	CbGbCtD
Methadone—ABCB1—Dactinomycin—muscle cancer	0.0726	0.0825	CbGbCtD
Methadone—CYP3A5—Vincristine—muscle cancer	0.0687	0.0781	CbGbCtD
Methadone—CYP3A5—Etoposide—muscle cancer	0.063	0.0715	CbGbCtD
Methadone—CYP2C8—Etoposide—muscle cancer	0.0606	0.0688	CbGbCtD
Methadone—CYP2B6—Doxorubicin—muscle cancer	0.0545	0.0619	CbGbCtD
Methadone—CYP1A2—Etoposide—muscle cancer	0.0469	0.0532	CbGbCtD
Methadone—ABCB1—Vincristine—muscle cancer	0.0447	0.0508	CbGbCtD
Methadone—ABCB1—Etoposide—muscle cancer	0.041	0.0466	CbGbCtD
Methadone—ABCB1—Doxorubicin—muscle cancer	0.028	0.0318	CbGbCtD
Methadone—ABCB1—Methotrexate—muscle cancer	0.0271	0.0308	CbGbCtD
Methadone—CYP3A4—Vincristine—muscle cancer	0.0268	0.0304	CbGbCtD
Methadone—CYP2D6—Doxorubicin—muscle cancer	0.0263	0.0299	CbGbCtD
Methadone—CYP3A4—Etoposide—muscle cancer	0.0246	0.0279	CbGbCtD
Methadone—CYP3A4—Doxorubicin—muscle cancer	0.0168	0.019	CbGbCtD
Methadone—Chronic hepatitis—Methotrexate—muscle cancer	0.0145	0.123	CcSEcCtD
Methadone—Abdominal cramps—Vincristine—muscle cancer	0.00266	0.0225	CcSEcCtD
Methadone—Drug interaction—Vincristine—muscle cancer	0.00194	0.0164	CcSEcCtD
Methadone—Phlebitis—Dactinomycin—muscle cancer	0.0017	0.0144	CcSEcCtD
Methadone—Osteoporosis—Methotrexate—muscle cancer	0.00156	0.0132	CcSEcCtD
Methadone—Multiple fractures—Methotrexate—muscle cancer	0.0015	0.0127	CcSEcCtD
Methadone—Fracture—Methotrexate—muscle cancer	0.0015	0.0127	CcSEcCtD
Methadone—Cardiomyopathy—Doxorubicin—muscle cancer	0.00148	0.0125	CcSEcCtD
Methadone—Hypothermia—Doxorubicin—muscle cancer	0.00135	0.0114	CcSEcCtD
Methadone—Body temperature decreased—Doxorubicin—muscle cancer	0.00135	0.0114	CcSEcCtD
Methadone—Lacrimation—Doxorubicin—muscle cancer	0.00128	0.0109	CcSEcCtD
Methadone—Cardiac arrest—Vincristine—muscle cancer	0.00124	0.0105	CcSEcCtD
Methadone—Urinary retention—Vincristine—muscle cancer	0.00124	0.0105	CcSEcCtD
Methadone—Lung disorder—Methotrexate—muscle cancer	0.00123	0.0104	CcSEcCtD
Methadone—Phlebitis—Etoposide—muscle cancer	0.00123	0.0104	CcSEcCtD
Methadone—Swelling—Etoposide—muscle cancer	0.0012	0.0101	CcSEcCtD
Methadone—Hypomagnesaemia—Doxorubicin—muscle cancer	0.00119	0.0101	CcSEcCtD
Methadone—Redness—Doxorubicin—muscle cancer	0.00112	0.00947	CcSEcCtD
Methadone—Cardiac failure—Etoposide—muscle cancer	0.00108	0.00917	CcSEcCtD
Methadone—Lung disorder—Doxorubicin—muscle cancer	0.00107	0.00903	CcSEcCtD
Methadone—Weight decreased—Vincristine—muscle cancer	0.00102	0.00864	CcSEcCtD
Methadone—Cardiac arrest—Etoposide—muscle cancer	0.00101	0.00851	CcSEcCtD
Methadone—Sweating—Vincristine—muscle cancer	0.000964	0.00816	CcSEcCtD
Methadone—Glossitis—Methotrexate—muscle cancer	0.000947	0.00801	CcSEcCtD
Methadone—Flushing—Dactinomycin—muscle cancer	0.000938	0.00794	CcSEcCtD
Methadone—Chills—Dactinomycin—muscle cancer	0.000907	0.00768	CcSEcCtD
Methadone—Hallucination—Vincristine—muscle cancer	0.000898	0.0076	CcSEcCtD
Methadone—Sweating increased—Etoposide—muscle cancer	0.00089	0.00753	CcSEcCtD
Methadone—Erythema—Dactinomycin—muscle cancer	0.00088	0.00745	CcSEcCtD
Methadone—Amenorrhoea—Doxorubicin—muscle cancer	0.00086	0.00728	CcSEcCtD
Methadone—Lacrimation increased—Doxorubicin—muscle cancer	0.00082	0.00694	CcSEcCtD
Methadone—Glossitis—Doxorubicin—muscle cancer	0.00082	0.00694	CcSEcCtD
Methadone—Pulmonary oedema—Methotrexate—muscle cancer	0.000777	0.00657	CcSEcCtD
Methadone—Ventricular tachycardia—Doxorubicin—muscle cancer	0.000755	0.00639	CcSEcCtD
Methadone—Dermatitis contact—Doxorubicin—muscle cancer	0.000747	0.00632	CcSEcCtD
Methadone—Agitation—Vincristine—muscle cancer	0.000722	0.00611	CcSEcCtD
Methadone—Oedema—Dactinomycin—muscle cancer	0.000718	0.00608	CcSEcCtD
Methadone—Vertigo—Vincristine—muscle cancer	0.000706	0.00598	CcSEcCtD
Methadone—Thrombocytopenia—Dactinomycin—muscle cancer	0.000703	0.00595	CcSEcCtD
Methadone—Anorexia—Dactinomycin—muscle cancer	0.000684	0.00579	CcSEcCtD
Methadone—Convulsion—Vincristine—muscle cancer	0.000681	0.00576	CcSEcCtD
Methadone—Flushing—Etoposide—muscle cancer	0.000679	0.00575	CcSEcCtD
Methadone—Pulmonary oedema—Doxorubicin—muscle cancer	0.000672	0.00569	CcSEcCtD
Methadone—Visual disturbance—Methotrexate—muscle cancer	0.000668	0.00566	CcSEcCtD
Methadone—Chills—Etoposide—muscle cancer	0.000656	0.00556	CcSEcCtD
Methadone—Anaphylactic shock—Vincristine—muscle cancer	0.000641	0.00543	CcSEcCtD
Methadone—Oedema—Vincristine—muscle cancer	0.000641	0.00543	CcSEcCtD
Methadone—Phlebitis—Doxorubicin—muscle cancer	0.000637	0.00539	CcSEcCtD
Methadone—Thrombocytopenia—Vincristine—muscle cancer	0.000628	0.00532	CcSEcCtD
Methadone—Decreased appetite—Dactinomycin—muscle cancer	0.000624	0.00528	CcSEcCtD
Methadone—Hyperhidrosis—Vincristine—muscle cancer	0.00062	0.00525	CcSEcCtD
Methadone—Pain—Dactinomycin—muscle cancer	0.000614	0.0052	CcSEcCtD
Methadone—Muscle spasms—Etoposide—muscle cancer	0.000612	0.00518	CcSEcCtD
Methadone—Anorexia—Vincristine—muscle cancer	0.000611	0.00518	CcSEcCtD
Methadone—Irritability—Methotrexate—muscle cancer	0.000604	0.00512	CcSEcCtD
Methadone—Hypotension—Vincristine—muscle cancer	0.000599	0.00507	CcSEcCtD
Methadone—Feeling abnormal—Dactinomycin—muscle cancer	0.000592	0.00501	CcSEcCtD
Methadone—Gastrointestinal pain—Dactinomycin—muscle cancer	0.000587	0.00497	CcSEcCtD
Methadone—Insomnia—Vincristine—muscle cancer	0.00058	0.00491	CcSEcCtD
Methadone—Vertigo—Etoposide—muscle cancer	0.000572	0.00484	CcSEcCtD
Methadone—Abdominal pain—Dactinomycin—muscle cancer	0.000568	0.0048	CcSEcCtD
Methadone—Body temperature increased—Dactinomycin—muscle cancer	0.000568	0.0048	CcSEcCtD
Methadone—Cardiac failure—Doxorubicin—muscle cancer	0.000562	0.00476	CcSEcCtD
Methadone—Loss of consciousness—Etoposide—muscle cancer	0.00056	0.00474	CcSEcCtD
Methadone—Decreased appetite—Vincristine—muscle cancer	0.000558	0.00472	CcSEcCtD
Methadone—Convulsion—Etoposide—muscle cancer	0.000552	0.00467	CcSEcCtD
Methadone—Pain—Vincristine—muscle cancer	0.000549	0.00464	CcSEcCtD
Methadone—Constipation—Vincristine—muscle cancer	0.000549	0.00464	CcSEcCtD
Methadone—Hypersensitivity—Dactinomycin—muscle cancer	0.000529	0.00448	CcSEcCtD
Methadone—Gastrointestinal pain—Vincristine—muscle cancer	0.000525	0.00444	CcSEcCtD
Methadone—Confusional state—Etoposide—muscle cancer	0.000524	0.00444	CcSEcCtD
Methadone—Cardiac arrest—Doxorubicin—muscle cancer	0.000521	0.00441	CcSEcCtD
Methadone—Anaphylactic shock—Etoposide—muscle cancer	0.00052	0.0044	CcSEcCtD
Methadone—Asthenia—Dactinomycin—muscle cancer	0.000515	0.00436	CcSEcCtD
Methadone—Thrombocytopenia—Etoposide—muscle cancer	0.000509	0.00431	CcSEcCtD
Methadone—Tachycardia—Etoposide—muscle cancer	0.000507	0.00429	CcSEcCtD
Methadone—Abdominal pain—Vincristine—muscle cancer	0.000507	0.00429	CcSEcCtD
Methadone—Body temperature increased—Vincristine—muscle cancer	0.000507	0.00429	CcSEcCtD
Methadone—Hyperhidrosis—Etoposide—muscle cancer	0.000502	0.00425	CcSEcCtD
Methadone—Orthostatic hypotension—Doxorubicin—muscle cancer	0.000501	0.00424	CcSEcCtD
Methadone—Hypokalaemia—Doxorubicin—muscle cancer	0.000499	0.00422	CcSEcCtD
Methadone—Anorexia—Etoposide—muscle cancer	0.000495	0.00419	CcSEcCtD
Methadone—Diarrhoea—Dactinomycin—muscle cancer	0.000491	0.00416	CcSEcCtD
Methadone—Nasopharyngitis—Doxorubicin—muscle cancer	0.00049	0.00415	CcSEcCtD
Methadone—Drowsiness—Methotrexate—muscle cancer	0.000488	0.00413	CcSEcCtD
Methadone—Hypotension—Etoposide—muscle cancer	0.000486	0.00411	CcSEcCtD
Methadone—Hypersensitivity—Vincristine—muscle cancer	0.000473	0.004	CcSEcCtD
Methadone—Sweating—Methotrexate—muscle cancer	0.000468	0.00396	CcSEcCtD
Methadone—Somnolence—Etoposide—muscle cancer	0.000462	0.00391	CcSEcCtD
Methadone—Asthenia—Vincristine—muscle cancer	0.00046	0.0039	CcSEcCtD
Methadone—Vomiting—Dactinomycin—muscle cancer	0.000457	0.00386	CcSEcCtD
Methadone—Rash—Dactinomycin—muscle cancer	0.000453	0.00383	CcSEcCtD
Methadone—Decreased appetite—Etoposide—muscle cancer	0.000452	0.00382	CcSEcCtD
Methadone—Pain—Etoposide—muscle cancer	0.000444	0.00376	CcSEcCtD
Methadone—Constipation—Etoposide—muscle cancer	0.000444	0.00376	CcSEcCtD
Methadone—Diarrhoea—Vincristine—muscle cancer	0.000439	0.00372	CcSEcCtD
Methadone—Weight increased—Doxorubicin—muscle cancer	0.000431	0.00365	CcSEcCtD
Methadone—Weight decreased—Doxorubicin—muscle cancer	0.000429	0.00363	CcSEcCtD
Methadone—Feeling abnormal—Etoposide—muscle cancer	0.000428	0.00362	CcSEcCtD
Methadone—Nausea—Dactinomycin—muscle cancer	0.000426	0.00361	CcSEcCtD
Methadone—Gastrointestinal pain—Etoposide—muscle cancer	0.000425	0.0036	CcSEcCtD
Methadone—Dizziness—Vincristine—muscle cancer	0.000424	0.00359	CcSEcCtD
Methadone—Drowsiness—Doxorubicin—muscle cancer	0.000423	0.00358	CcSEcCtD
Methadone—Visual impairment—Methotrexate—muscle cancer	0.000422	0.00357	CcSEcCtD
Methadone—Urticaria—Etoposide—muscle cancer	0.000413	0.00349	CcSEcCtD
Methadone—Abdominal pain—Etoposide—muscle cancer	0.000411	0.00348	CcSEcCtD
Methadone—Body temperature increased—Etoposide—muscle cancer	0.000411	0.00348	CcSEcCtD
Methadone—Vomiting—Vincristine—muscle cancer	0.000408	0.00345	CcSEcCtD
Methadone—Sweating—Doxorubicin—muscle cancer	0.000405	0.00343	CcSEcCtD
Methadone—Rash—Vincristine—muscle cancer	0.000404	0.00342	CcSEcCtD
Methadone—Dermatitis—Vincristine—muscle cancer	0.000404	0.00342	CcSEcCtD
Methadone—Headache—Vincristine—muscle cancer	0.000402	0.0034	CcSEcCtD
Methadone—Chills—Methotrexate—muscle cancer	0.000393	0.00333	CcSEcCtD
Methadone—Bradycardia—Doxorubicin—muscle cancer	0.000386	0.00327	CcSEcCtD
Methadone—Hypersensitivity—Etoposide—muscle cancer	0.000383	0.00324	CcSEcCtD
Methadone—Erythema—Methotrexate—muscle cancer	0.000381	0.00323	CcSEcCtD
Methadone—Nausea—Vincristine—muscle cancer	0.000381	0.00323	CcSEcCtD
Methadone—Asthenia—Etoposide—muscle cancer	0.000373	0.00316	CcSEcCtD
Methadone—Pruritus—Etoposide—muscle cancer	0.000368	0.00311	CcSEcCtD
Methadone—Visual impairment—Doxorubicin—muscle cancer	0.000366	0.00309	CcSEcCtD
Methadone—Diarrhoea—Etoposide—muscle cancer	0.000356	0.00301	CcSEcCtD
Methadone—Flushing—Doxorubicin—muscle cancer	0.000352	0.00298	CcSEcCtD
Methadone—Dizziness—Etoposide—muscle cancer	0.000344	0.00291	CcSEcCtD
Methadone—Vertigo—Methotrexate—muscle cancer	0.000343	0.0029	CcSEcCtD
Methadone—Chills—Doxorubicin—muscle cancer	0.00034	0.00288	CcSEcCtD
Methadone—Arrhythmia—Doxorubicin—muscle cancer	0.000339	0.00287	CcSEcCtD
Methadone—Convulsion—Methotrexate—muscle cancer	0.00033	0.0028	CcSEcCtD
Methadone—Vomiting—Etoposide—muscle cancer	0.00033	0.0028	CcSEcCtD
Methadone—Erythema—Doxorubicin—muscle cancer	0.00033	0.0028	CcSEcCtD
Methadone—Rash—Etoposide—muscle cancer	0.000328	0.00277	CcSEcCtD
Methadone—Dermatitis—Etoposide—muscle cancer	0.000327	0.00277	CcSEcCtD
Methadone—Headache—Etoposide—muscle cancer	0.000326	0.00276	CcSEcCtD
Methadone—Muscle spasms—Doxorubicin—muscle cancer	0.000318	0.00269	CcSEcCtD
Methadone—Confusional state—Methotrexate—muscle cancer	0.000314	0.00266	CcSEcCtD
Methadone—Anaphylactic shock—Methotrexate—muscle cancer	0.000311	0.00263	CcSEcCtD
Methadone—Nausea—Etoposide—muscle cancer	0.000309	0.00261	CcSEcCtD
Methadone—Thrombocytopenia—Methotrexate—muscle cancer	0.000305	0.00258	CcSEcCtD
Methadone—Agitation—Doxorubicin—muscle cancer	0.000303	0.00257	CcSEcCtD
Methadone—Hyperhidrosis—Methotrexate—muscle cancer	0.000301	0.00255	CcSEcCtD
Methadone—Vertigo—Doxorubicin—muscle cancer	0.000297	0.00251	CcSEcCtD
Methadone—Anorexia—Methotrexate—muscle cancer	0.000297	0.00251	CcSEcCtD
Methadone—Syncope—Doxorubicin—muscle cancer	0.000296	0.00251	CcSEcCtD
Methadone—Palpitations—Doxorubicin—muscle cancer	0.000292	0.00247	CcSEcCtD
Methadone—Hypotension—Methotrexate—muscle cancer	0.000291	0.00246	CcSEcCtD
Methadone—Loss of consciousness—Doxorubicin—muscle cancer	0.00029	0.00246	CcSEcCtD
Methadone—Convulsion—Doxorubicin—muscle cancer	0.000286	0.00242	CcSEcCtD
Methadone—Insomnia—Methotrexate—muscle cancer	0.000282	0.00238	CcSEcCtD
Methadone—Anxiety—Doxorubicin—muscle cancer	0.00028	0.00237	CcSEcCtD
Methadone—Somnolence—Methotrexate—muscle cancer	0.000277	0.00234	CcSEcCtD
Methadone—Dry mouth—Doxorubicin—muscle cancer	0.000275	0.00233	CcSEcCtD
Methadone—Confusional state—Doxorubicin—muscle cancer	0.000272	0.0023	CcSEcCtD
Methadone—Decreased appetite—Methotrexate—muscle cancer	0.000271	0.00229	CcSEcCtD
Methadone—Oedema—Doxorubicin—muscle cancer	0.00027	0.00228	CcSEcCtD
Methadone—Anaphylactic shock—Doxorubicin—muscle cancer	0.00027	0.00228	CcSEcCtD
Methadone—Pain—Methotrexate—muscle cancer	0.000266	0.00225	CcSEcCtD
Methadone—Shock—Doxorubicin—muscle cancer	0.000265	0.00224	CcSEcCtD
Methadone—Thrombocytopenia—Doxorubicin—muscle cancer	0.000264	0.00223	CcSEcCtD
Methadone—Tachycardia—Doxorubicin—muscle cancer	0.000263	0.00223	CcSEcCtD
Methadone—Hyperhidrosis—Doxorubicin—muscle cancer	0.000261	0.00221	CcSEcCtD
Methadone—Anorexia—Doxorubicin—muscle cancer	0.000257	0.00217	CcSEcCtD
Methadone—Feeling abnormal—Methotrexate—muscle cancer	0.000257	0.00217	CcSEcCtD
Methadone—Gastrointestinal pain—Methotrexate—muscle cancer	0.000255	0.00215	CcSEcCtD
Methadone—Hypotension—Doxorubicin—muscle cancer	0.000252	0.00213	CcSEcCtD
Methadone—Urticaria—Methotrexate—muscle cancer	0.000247	0.00209	CcSEcCtD
Methadone—Abdominal pain—Methotrexate—muscle cancer	0.000246	0.00208	CcSEcCtD
Methadone—Body temperature increased—Methotrexate—muscle cancer	0.000246	0.00208	CcSEcCtD
Methadone—Insomnia—Doxorubicin—muscle cancer	0.000244	0.00206	CcSEcCtD
Methadone—Somnolence—Doxorubicin—muscle cancer	0.00024	0.00203	CcSEcCtD
Methadone—Decreased appetite—Doxorubicin—muscle cancer	0.000234	0.00198	CcSEcCtD
Methadone—Constipation—Doxorubicin—muscle cancer	0.00023	0.00195	CcSEcCtD
Methadone—Pain—Doxorubicin—muscle cancer	0.00023	0.00195	CcSEcCtD
Methadone—Hypersensitivity—Methotrexate—muscle cancer	0.000229	0.00194	CcSEcCtD
Methadone—Asthenia—Methotrexate—muscle cancer	0.000223	0.00189	CcSEcCtD
Methadone—Feeling abnormal—Doxorubicin—muscle cancer	0.000222	0.00188	CcSEcCtD
Methadone—Gastrointestinal pain—Doxorubicin—muscle cancer	0.00022	0.00187	CcSEcCtD
Methadone—Pruritus—Methotrexate—muscle cancer	0.00022	0.00186	CcSEcCtD
Methadone—Urticaria—Doxorubicin—muscle cancer	0.000214	0.00181	CcSEcCtD
Methadone—Abdominal pain—Doxorubicin—muscle cancer	0.000213	0.0018	CcSEcCtD
Methadone—Body temperature increased—Doxorubicin—muscle cancer	0.000213	0.0018	CcSEcCtD
Methadone—Diarrhoea—Methotrexate—muscle cancer	0.000213	0.0018	CcSEcCtD
Methadone—Dizziness—Methotrexate—muscle cancer	0.000206	0.00174	CcSEcCtD
Methadone—Hypersensitivity—Doxorubicin—muscle cancer	0.000199	0.00168	CcSEcCtD
Methadone—Vomiting—Methotrexate—muscle cancer	0.000198	0.00168	CcSEcCtD
Methadone—Rash—Methotrexate—muscle cancer	0.000196	0.00166	CcSEcCtD
Methadone—Dermatitis—Methotrexate—muscle cancer	0.000196	0.00166	CcSEcCtD
Methadone—Headache—Methotrexate—muscle cancer	0.000195	0.00165	CcSEcCtD
Methadone—Asthenia—Doxorubicin—muscle cancer	0.000193	0.00164	CcSEcCtD
Methadone—Pruritus—Doxorubicin—muscle cancer	0.000191	0.00161	CcSEcCtD
Methadone—Nausea—Methotrexate—muscle cancer	0.000185	0.00156	CcSEcCtD
Methadone—Diarrhoea—Doxorubicin—muscle cancer	0.000184	0.00156	CcSEcCtD
Methadone—Dizziness—Doxorubicin—muscle cancer	0.000178	0.00151	CcSEcCtD
Methadone—Vomiting—Doxorubicin—muscle cancer	0.000171	0.00145	CcSEcCtD
Methadone—Rash—Doxorubicin—muscle cancer	0.00017	0.00144	CcSEcCtD
Methadone—Dermatitis—Doxorubicin—muscle cancer	0.00017	0.00144	CcSEcCtD
Methadone—Headache—Doxorubicin—muscle cancer	0.000169	0.00143	CcSEcCtD
Methadone—Nausea—Doxorubicin—muscle cancer	0.00016	0.00136	CcSEcCtD
Methadone—CHRNA10—tendon—muscle cancer	9.76e-05	0.0736	CbGeAlD
Methadone—CHRNA10—vagina—muscle cancer	9.05e-05	0.0683	CbGeAlD
Methadone—CHRNA10—head—muscle cancer	8.36e-05	0.0631	CbGeAlD
Methadone—CHRNA10—testis—muscle cancer	8.08e-05	0.061	CbGeAlD
Methadone—OPRD1—renal system—muscle cancer	7.78e-05	0.0587	CbGeAlD
Methadone—GRIN3A—head—muscle cancer	7.39e-05	0.0558	CbGeAlD
Methadone—GRIN3A—testis—muscle cancer	7.14e-05	0.0539	CbGeAlD
Methadone—CYP2C18—vagina—muscle cancer	6.23e-05	0.047	CbGeAlD
Methadone—OPRD1—head—muscle cancer	5.2e-05	0.0393	CbGeAlD
Methadone—OPRK1—head—muscle cancer	4.99e-05	0.0377	CbGeAlD
Methadone—HTR3A—head—muscle cancer	3.87e-05	0.0292	CbGeAlD
Methadone—OPRM1—head—muscle cancer	3.55e-05	0.0268	CbGeAlD
Methadone—OPRM1—testis—muscle cancer	3.43e-05	0.0259	CbGeAlD
Methadone—CYP2C8—renal system—muscle cancer	3.19e-05	0.0241	CbGeAlD
Methadone—CYP1A2—renal system—muscle cancer	2.99e-05	0.0225	CbGeAlD
Methadone—CYP19A1—head—muscle cancer	2.98e-05	0.0225	CbGeAlD
Methadone—CYP19A1—testis—muscle cancer	2.88e-05	0.0217	CbGeAlD
Methadone—CYP3A5—renal system—muscle cancer	2.88e-05	0.0217	CbGeAlD
Methadone—CYP2B6—renal system—muscle cancer	2.86e-05	0.0216	CbGeAlD
Methadone—CYP2C19—vagina—muscle cancer	2.65e-05	0.02	CbGeAlD
Methadone—CYP2C8—vagina—muscle cancer	2.31e-05	0.0174	CbGeAlD
Methadone—CYP3A4—renal system—muscle cancer	2.16e-05	0.0163	CbGeAlD
Methadone—CYP2D6—renal system—muscle cancer	2.13e-05	0.0161	CbGeAlD
Methadone—CYP3A5—vagina—muscle cancer	2.09e-05	0.0157	CbGeAlD
Methadone—CYP2B6—vagina—muscle cancer	2.07e-05	0.0156	CbGeAlD
Methadone—CYP2C8—testis—muscle cancer	2.06e-05	0.0156	CbGeAlD
Methadone—ABCB1—embryo—muscle cancer	2.02e-05	0.0153	CbGeAlD
Methadone—CYP2B6—head—muscle cancer	1.92e-05	0.0145	CbGeAlD
Methadone—CYP2B6—testis—muscle cancer	1.85e-05	0.014	CbGeAlD
Methadone—ABCB1—renal system—muscle cancer	1.53e-05	0.0115	CbGeAlD
Methadone—CYP2D6—head—muscle cancer	1.42e-05	0.0107	CbGeAlD
Methadone—CYP2D6—testis—muscle cancer	1.37e-05	0.0104	CbGeAlD
Methadone—ABCB1—bone marrow—muscle cancer	1.16e-05	0.00873	CbGeAlD
Methadone—ABCB1—vagina—muscle cancer	1.11e-05	0.00836	CbGeAlD
Methadone—ABCB1—head—muscle cancer	1.02e-05	0.00773	CbGeAlD
Methadone—ABCB1—testis—muscle cancer	9.89e-06	0.00746	CbGeAlD
